Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology
    • 1 - 100 Employee
    • Chief Technology Officer
      • Feb 2017 - Present

    • CEO Alexis Bio
      • Jul 2021 - Present

      Boston, Massachusetts, United States

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • CEO, Co-Founder
      • Jan 2016 - Oct 2021

      Boston, MA We Engineer Life. You are the Designer. XenoTherapeutics is a clinical-stage cell therapy company engineering personalized cells, tissues, and organs for transplantation. Our cell therapy is guided by a patient’s unique genetic makeup, ensuring our personalized products avoid rejection by the human immune system. Our data-driven science combines fundamental principles with proven technologies, revolutionizing what’s uniquely possible for you.

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Surgical Research Fellow
      • Nov 2012 - Aug 2014

      Transplantation and Biology Research Center (TBRC) @ MGH

    • United States
    • Armed Forces
    • 700 & Above Employee
    • Officer
      • May 2000 - Sep 2013

      Various

Education

  • Johns Hopkins Whiting School of Engineering
    Doctor of Engineering, DEng, Genetic Engineering, Molecular Biology, and Transplant Immunology
    2021 - 2023
  • Geisel School of Medicine at Dartmouth
    Graduate Degree, Program in Experimental & Molecular Medicine
    2017 - 2019
  • Massachusetts Institute of Technology
    Masters of Science, Mechanical Engineering
    2009 - 2011
  • Southern New Hampshire University
    Masters of Business Administration, Economics
    2015 - 2017
  • Massachusetts Bay Community College
    Paramedicine Program
    2013 - 2013
  • University of Florida
    Bachelor's of Science, Mechanical Engineering
    1999 - 2003

Community

You need to have a working account to view this content. Click here to join now